These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2318945

  • 21. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.
    Miell JP, Corder R, Pralong FP, Gaillard RC.
    J Clin Endocrinol Metab; 1991 Mar; 72(3):675-81. PubMed ID: 1671785
    [Abstract] [Full Text] [Related]

  • 22. Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in man.
    Ghigo E, Miola C, Aimaretti G, Valente F, Procopio M, Arvat E, Yin-Zhang W, Camanni F.
    Metabolism; 1992 Sep; 41(9):1000-3. PubMed ID: 1355580
    [Abstract] [Full Text] [Related]

  • 23. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
    Barbarino A, Corsello SM, Della Casa S, Tofani A, Sciuto R, Rota CA, Bollanti L, Barini A.
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
    [Abstract] [Full Text] [Related]

  • 24. Stimulated growth hormone (GH) secretion in children with delays in pubertal development before and after the onset of puberty: relationship with peripheral plasma GH-releasing hormone and somatostatin levels.
    Saggese G, Cesaretti G, Giannessi N, Bracaloni C, Cinquanta L, Cioni C.
    J Clin Endocrinol Metab; 1992 Feb; 74(2):272-8. PubMed ID: 1346143
    [Abstract] [Full Text] [Related]

  • 25. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M, Bossoni S, Alí A, Doga M, Reimondo G, Milani G, Peretti P, Manelli F, Angeli A, Giustina A.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [Abstract] [Full Text] [Related]

  • 26. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
    Mota A, Bento A, Peñalva A, Pombo M, Dieguez C.
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1973-7. PubMed ID: 7775648
    [Abstract] [Full Text] [Related]

  • 27. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
    Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Camanni F.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3323-7. PubMed ID: 8784091
    [Abstract] [Full Text] [Related]

  • 28. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP, Christensen SE, Lundbaek K.
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [Abstract] [Full Text] [Related]

  • 29. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.
    Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML.
    J Clin Endocrinol Metab; 2002 May; 87(5):2067-79. PubMed ID: 11994342
    [Abstract] [Full Text] [Related]

  • 30. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K, Sasaki A, Sato S, Goh M, Yoshinaga K.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [Abstract] [Full Text] [Related]

  • 31. Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children.
    Donnadieu M, Evain-Brion D, Tonon MC, Vaudry H, Job JC.
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1132-4. PubMed ID: 3923020
    [Abstract] [Full Text] [Related]

  • 32. Blunted GH response to growth hormone-releasing hormone (GHRH) alone or combined with arginine in non-insulin-dependent diabetes mellitus.
    Martina V, Bruno G, Tagliabue M, Bertaina S, Maccario M, Grottoli S, Procopio M, Ozzello A, Camanni F.
    Horm Metab Res; 1995 Jan; 27(1):26-30. PubMed ID: 7729789
    [Abstract] [Full Text] [Related]

  • 33. Variability of growth hormone response to pharmacological and sleep tests performed twice in short children.
    Tassoni P, Cacciari E, Cau M, Colli C, Tosi M, Zucchini S, Cicognani A, Pirazzoli P, Salardi S, Balsamo A.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):230-4. PubMed ID: 2370294
    [Abstract] [Full Text] [Related]

  • 34. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
    [Abstract] [Full Text] [Related]

  • 35. Age-related decrease in plasma growth hormone: response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
    Tanaka K, Inoue S, Shiraki J, Shishido T, Saito M, Numata K, Takamura Y.
    Metabolism; 1991 Dec; 40(12):1257-62. PubMed ID: 1961117
    [Abstract] [Full Text] [Related]

  • 36. Diminished growth hormone secretion in blind males after L-dopa stimulation.
    Fatranská M, Jurcovicová J, Németh S, Vigas M.
    Endocrinol Exp; 1988 Dec; 22(4):243-8. PubMed ID: 3243205
    [Abstract] [Full Text] [Related]

  • 37. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M, Guyda H, Van Vliet G, Tannenbaum GS.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [Abstract] [Full Text] [Related]

  • 38. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M, Frohman LA.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
    [Abstract] [Full Text] [Related]

  • 39. Neurotransmitter control of growth hormone secretion in children after cranial radiation therapy.
    Jorgensen EV, Schwartz ID, Hvizdala E, Barbosa J, Phuphanich S, Shulman DI, Root AW, Estrada J, Hu CS, Bercu BB.
    J Pediatr Endocrinol; 1993 Jul; 6(2):131-42. PubMed ID: 8102303
    [Abstract] [Full Text] [Related]

  • 40. Reduced growth hormone response to L-dopa and pyridostigmine in obesity.
    Lee EJ, Kim KR, Lee KM, Lim SK, Lee HC, Lee JH, Lee DJ, Huh KB.
    Int J Obes Relat Metab Disord; 1994 Jul; 18(7):465-8. PubMed ID: 7920871
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.